In a definitive M&A agreement, Hill-Rom Holdings has completed the $400 million purchase of privately held Aspen Surgical Products.
Aspen Surgical provides a portfolio of well-established surgical consumable and specialty medical products focused on improving the safety of patients and health care professionals.
The M&A of Aspen Surgical further develops Hill-Rom’s surgical business, adding a portfolio of consumable products and expanding its position in North American and European surgical markets.
Hill-Rom, President and CEO, John J. Greisch believes that this M&A deal further expands the company’s global portfolio beyond its core franchise with a business that is immediately accretive to earnings per share and adds recurring revenue to its existing surgical platform.
The M&A transaction was funded with a combination of cash and bank debt.
For further deal information visit Current Agreements (subscription required)
Read: more on M&A deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity